Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
6.99
-0.13 (-1.83%)
At close: Aug 7, 2025, 4:00 PM
6.88
-0.11 (-1.57%)
Pre-market: Aug 8, 2025, 4:26 AM EDT
Paycor HCM Stock Forecast
Stock Price Forecast
The 5 analysts that cover Paycor HCM stock have a consensus rating of "Buy" and an average price target of $18.4, which forecasts a 163.23% increase in the stock price over the next year. The lowest target is $10 and the highest is $24.
Price Target: $18.40 (+163.23%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Paycor HCM stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +186.12% | Jul 28, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $23 → $24 | Buy | Maintains | $23 → $24 | +243.35% | Jun 3, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $21 → $23 | Buy | Maintains | $21 → $23 | +229.04% | May 14, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $21 | Buy | Reiterates | $21 | +200.43% | Feb 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +157.51% | Feb 11, 2025 |
Financial Forecast
Revenue This Year
64.28M
from 67.64M
Decreased by -4.96%
Revenue Next Year
66.89M
from 64.28M
Increased by 4.05%
EPS This Year
-4.59
from -5.48
EPS Next Year
-3.48
from -4.59
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 68.8M | 73.4M | 69.7M | ||
| Avg | 64.3M | 66.9M | 66.5M | ||
| Low | 60.5M | 57.3M | 62.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.7% | 14.2% | 4.2% | ||
| Avg | -5.0% | 4.1% | -0.6% | ||
| Low | -10.6% | -10.8% | -6.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -4.35 | -2.21 | -1.47 | |
| Avg | -4.59 | -3.48 | -1.43 | |
| Low | -4.93 | -4.73 | -1.37 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.